HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Bone abnormalities in diabetic hemodialysis patients].

Abstract
In patients with end stage renal disease, metabolic bone abnormalities are frequently seen. Diabetes may affect bone metabolism through various mechanisms, including hyperglycemia, insulin deficiency, and accumulation of advanced glycation end-products. Bone disease in hemodialysis patients with diabetes mellitus is characterized by low bone turnover, resulting from either impaired secretion of parathyroid hormone or osteoblast dysfunction. The prevalence rate of vertebral fractures in diabetic hemodialysis patients was 32%, which was greater than that of non-diabetic hemodialysis patients (13%). In non-diabetic hemodialysis patients, those with vertebral fracture showed significantly lower bone mineral density in either lumbar spine or distal one third of radius than the respective value in those without fracture. However, in diabetic hemodialysis patients, neither bone mineral density in lumbar spine nor distal one third of radius was significantly lower in those with vertebral fracture than in those without.
AuthorsSenji Okuno, Masaaki Inaba
JournalClinical calcium (Clin Calcium) Vol. 16 Issue 8 Pg. 1344-50 (Aug 2006) ISSN: 0917-5857 [Print] Japan
PMID16883043 (Publication Type: English Abstract, Journal Article)
Topics
  • Aged
  • Bone Diseases (etiology)
  • Bone and Bones (metabolism)
  • Diabetic Nephropathies (metabolism)
  • Humans
  • Kidney Failure, Chronic (metabolism)
  • Renal Dialysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: